ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novo makes another early-stage diabetes bet with Ziylo buy
evaluate
August 21, 2018Intensifying pricing pressure in diabetes has not put?Novo Nordisk off going after new technologies. The group’s latest acquisition, the UK company Ziylo, could lead to the development of insulin that “switches off” when blood glucose levels are too low.
Pharma Sources Insight January 2025
